Navigation Links
Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Date:4/26/2012

PITTSBURGH, April 26, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three months ended March 31, 2012.

Financial Results

  • Adjusted diluted EPS of $0.52 for the three months ended March 31, 2012 compared to $0.44 for the same prior year period, an increase of 18%;
  • Adjusted total revenues of $1.58 billion for the three months ended March 31, 2012 compared to $1.45 billion for the same prior year period, an increase of 9%.  Total revenues of $1.59 billion for the three months ended March 31, 2012 compared to $1.45 billion for the same prior year period, an increase of 10%;
  • On a GAAP basis, diluted EPS of $0.30 for three months ended March 31, 2012 compared to $0.23 for the same prior year period, an increase of 30%;
  • Mylan's Chief Executive Officer, Heather Bresch said:  "Our diverse global platform has once again delivered strong results, representing a great start to 2012.  Double-digit growth in our North American, Asia Pacific and Specialty businesses allowed us to deliver robust financial results despite continued macroeconomic headwinds in certain regions, specifically Europe and Australia." 

    Bresch continued: "We are reaffirming our 2012 guidance of $2.30 to $2.50 per share, and we continue to see opportunities for upside during the year.  Further, the strength of our platform, first-in-class science and robust product portfolio give us continued confidence in our 2013 target of $2.75 per share, and in our growth in the years beyond." 

    John Sheehan, Mylan's Chief Financial Officer added:  "I am pleased with our first quarter results, which were consistent with our expectations.  Moving forward, we anticipate earnings in the second quarter to be in line with the first, before accelerating into the third quarter, which will be by
    '/>"/>

    SOURCE Mylan Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
    2. Mylan Launches Generic Version of Zyprexa® Tablets
    3. Mylan Launches First Generic Version of Lescol® Capsules
    4. Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast
    5. Mylan One of First to Launch Generic Version of Boniva®
    6. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
    7. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
    8. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
    9. Mylan Secures an Additional $300 Million of Committed Financing
    10. Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
    11. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... , Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... blood instrumentation and consumables to the medical, research and ... Chairman and Chief Executive Officer, will present at the ... 2014 on Tuesday, September 9, 2014 at 12:30 p.m. ... Berkshire Place Hotel in New York City ...
    (Date:8/29/2014)... , August 29, 2014 ... and collaboration software has announced a major new deal ... founded by renowned pathology expert, Dr. Marius Nap ... of the 26th European Congress of Pathology which is ... the ExCeL Arena, London where ...
    (Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
    Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
    ... Global pharmaceutical outsourcing has become increasingly prevalent, ... environment that has pharmaceutical and life sciences executives on ... PwC US and published today by Axendia, Inc., a ... 50 percent of pharmaceutical and life sciences executives surveyed ...
    ... NEWTOWN, Pa., Oct. 27 Essential Pharmaceuticals, LLC, ... and solutions to the life sciences market, announced ... distribution of three distinct animal-component-free products: serum replacement, ... the LiforCell® name: Cell-Ess™ ...
    Cached Medicine Technology:As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 2As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 3As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 4As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 5Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical 2
    (Date:8/29/2014)... August 30, 2014 Famous review website ... GoDaddy and GreenGeeks are the most recommended suppliers for ... hosting products (including VPS and cloud hosting) at affordable ... plans. The monthly price for shared hosting plans depends ... a web hosting provider known for its flexible hosting ...
    (Date:8/29/2014)... (PRWEB) August 30, 2014 Skmen.com, a famous ... of sexy mini dresses . At the moment, all ... 30 percent off. The deadline of the promotion is September ... worldwide clients with the latest information about our hot designs, ... online store. We hope to help all stylish ladies to ...
    (Date:8/29/2014)... August 29, 2014 DailyGossip.org publishes a ... an absolutely unique method of curing multiple sclerosis in ... was created by Dr. Gary M. Levin, who has ... started to become interested in alternative remedies for a ... remedies cannot be effective in all cases for the ...
    (Date:8/29/2014)... Chicago (PRWEB) August 29, 2014 Champion ... against muscle disease by appearing on the annual MDA ... Sunday, Aug. 31, 9/8c on ABC television stations across ... champion and current host of “All In, with Laila ... Fall Out Boy during the Muscular Dystrophy Association's nationally ...
    (Date:8/29/2014)... According to a CNN article, entitled Medical ... new study found that those states who legalized medical ... decrease in the number of painkiller overdoses seen. By ... and comparing various states with and without legalized medical ... about a 25% decrease in painkiller prescription overdoses in ...
    Breaking Medicine News(10 mins):Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2Health News:Champion Boxers Fight Back Against Muscle Disease 2Health News:Champion Boxers Fight Back Against Muscle Disease 3Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3
    ... Publications LLC today,announced that its highly anticipated book ... will be released on April 28, 2008 in ... online book retailers,including Amazon.com., *(PHOTO 72dpi: ... Creating Your Dream Life.) An entirely new ...
    ... by 55 percent from baseline ,severe, to moderately ... by 53 percent and increased patients, mobility almost three-fold, ... million Americans,suffer from osteoarthritis, with half a million Americans ... to be published in the April 2008,edition (Volume 22, ...
    ... PARK, Ill., April 16 Abbott (NYSE:,ABT) announced ... Japanese,Ministry of Health, Labour and Welfare for HUMIRA(R) ... with inadequate response to,conventional therapy. This approval is ... and will co-market HUMIRA with Eisai Co., Ltd. ...
    ... First in Nation to Embrace the Vending Industry,s ... ... The nation,s vending industry will,unveil tomorrow a new nationwide ... Association (NAMA),President Richard M. Geerdes, NCE announced today. The new ...
    ... researchers have identified a gene that is necessary in ... because expression of this gene is frequently suppressed in ... Charles Lopez, M.D., Ph.D., OHSU Cancer Institute (hematology/medical oncology), ... at a minisymposium on Wednesday April 16 at 10:30 ...
    ... Industry supports hundreds of programs helping millions in ... WASHINGTON, April 16 The worldwide,pharmaceutical industry ... research-based biopharmaceutical companies, global,health leaders and policymakers together ... the developing world., Serving as a convening ...
    Cached Medicine News:Health News:21 Days to Creating Your Dream Life Will be Unleashed on April 28, 2008 2Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 2Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 3Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 4Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 5Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 2Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 3Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 4Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 5Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 6Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 7Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 2Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 3Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 4Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3
    Stainless steel lancet blade in stainless steel....
    In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
    AXIOM Multistar is a ceiling-mounted single plane C-Arm system for universal angiography, diagnostics and intervention...
    ... supports the cardiac workflow through Xper: a ... personalized user settings. In addition Xper integrates ... user interface. For example the interventional tools ... controlled from tableside.,The excellent image quality and ...
    Medicine Products: